MINNEAPOLIS, Nov. 20,
2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH), a global life sciences company providing innovative tools
and bioactive reagents for the research and clinical diagnostic
communities today announced a partnership with Leader Life
Sciences. Under the agreement, Leader Life Sciences becomes a
distributor of Bio-Techne's portfolio across the Gulf Cooperation
Council (GCC) countries, which include Bahrain, Oman, Qatar,
Saudi Arabia, and United Arab Emirates.
Founded in 2020, Leader Life Sciences is a scientific solutions
provider dedicated to empowering the research and diagnostic
community in the Middle East and
North Africa (MENA) region.
Serving as a catalyst for innovation, they collaborate with private
and public research centers, educational institutions, and
healthcare facilities to bring scientific visions to life. Their
expertise spans a wide range of domains, including lab automation,
digital pathology, turnkey laboratory projects and
diagnostics, and beyond. Under this agreement, Leader
Life Sciences will distribute Bio-Techne's extensive portfolio of
innovative products, including antibodies, proteins, immunoassay
kits, enzymes, small molecules, proteomic analysis
instruments, and spatial biology tools to biopharma companies,
laboratories, hospitals, and universities in the GCC region.
"We are excited to partner with Leader Life Sciences to expand
the reach of our products and services throughout the GCC
countries," said Dr. Peter Schüßler, Vice President and General
Manager of Bio-Techne's EMEA region. "Leader Life Sciences'
extensive distribution network and industry expertise paired with
Bio-Techne's innovative portfolio is the ideal combination to
catalyze advances in science and medicine in the region."
"We are thrilled to partner with Bio-Techne, a global leader in
innovative life sciences solutions. This collaboration marks a
pivotal step in our mission to empower researchers, scientists, and
diagnosticians in the MENA region. Together, we are committed to
providing cutting-edge technologies that accelerate discovery and
enhance advancements in diagnostics, reinforcing our dedication to
driving progress of the scientific community of the region," said
Nirmal Kumar, Managing Director at
Leader Life Sciences.
For more information about Bio-Techne and its range of products
and services, visit our Website.
About Bio-Techne:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences
company providing innovative tools and bioactive reagents for the
research and clinical diagnostic communities. Bio-Techne products
assist scientific investigations into biological processes and the
nature and progress of specific diseases. They aid in drug
discovery efforts and provide the means for accurate clinical tests
and diagnoses. With hundreds of thousands of products in its
portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has
over 3,100 employees worldwide. For more information on Bio-Techne
and its brands, please
visit https://www.bio-techne.com or follow the Company on
social media at: Facebook, LinkedIn, Twitter or YouTube.
Bio-Techne Contact:
David Clair, Vice President,
Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
Leader Life Sciences Contact:
rahaf@leaderlifesciences.com
nirmal@leaderlifesciences.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-new-distribution-agreement-with-leader-life-sciences-302311108.html
SOURCE Bio-Techne Corporation
